The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Development and validation of a cardiovascular risk prediction model in type 1 diabetes
Open accessAbstract
Aims/hypothesis: We aimed to report current rates of CVD in type 1 diabetes and to develop a CVD risk prediction tool for type 1 diabetes. Methods: A cohort of 27,527 people with type 1 diabetes without prior CVD was derived from the national register in Scotland. Incident CVD events during 199,552 person-years of follow-up were ascertained using hospital admissions and death registers. A Poisson regression model of CVD was developed and then validated in the Swedish National Diabetes Register (n = 33,183). We compared the percentage with a high 10 year CVD risk (i.e., ≥10%) using the model with the percentage eligible for statins using current guidelines by age. Results: The age-standardised rate of CVD per 100,000 person-years was 4070 and 3429 in men and women, respectively, with type 1 diabetes in Scotland, and 4014 and 3956 in men and women in Sweden. The final model was well calibrated (Hosmer–Lemeshow test p > 0.05) and included a further 22 terms over a base model of age, sex and diabetes duration (C statistic 0.82; 95% CI 0.81, 0.83). The model increased the base model C statistic from 0.66 to 0.80, from 0.60 to 0.75 and from 0.62 to 0.68 in those aged <40, 40–59 and ≥ 60 years, respectively (all p values <0.005). The model required minimal calibration in Sweden and had a C statistic of 0.85. Under current guidelines, >90% of those aged 20–39 years and 100% of those≥40 years with type 1 diabetes were eligible for statins, but it was not until age 65 upwards that 100% had a modelled risk of CVD≥10% in 10 years. Conclusions/interpretation: A prediction tool such as that developed here can provide individualised risk predictions. This 10 year CVD risk prediction tool could facilitate patient discussions regarding appropriate statin prescribing. Apart from 10 year risk, such discussions may also consider longer-term CVD risk, the potential for greater benefits from early vs later statin intervention, the potential impact on quality of life of an early CVD event and evidence on safety, all of which could influence treatment decisions, particularly in younger people with type 1 diabetes. Graphical abstract:
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Aerobic fitness improved HbA1c in patients with T1DM”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [795]
Experimental — accuracy not yet measuredIn the citing paper
“but did not affect BMI, BP, and lipids.795”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [795]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Cosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz486 · Cited by 4,763
Self-citationCollaborators, C. T. T. (. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60367-5 · Cited by 2,833
Amelia II: A Program for Missing Data
Honaker, J., King, G., & Blackwell, M. (2011) · Journal of Statistical Software · doi:10.18637/jss.v045.i07 · Cited by 2,552
Hippisley-Cox, J., Coupland, C., & Brindle, P. (2017) · BMJ · doi:10.1136/bmj.j2099 · Cited by 1,703
Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2
Hippisley-Cox, J., Coupland, C., Vinogradova, Y., Robson, J., Minhas, R., Sheikh, A., & Brindle, P. (2008) · BMJ · doi:10.1136/bmj.39609.449676.25 · Cited by 1,459
Mortality and cardiovascular disease in type 1 and type 2 diabetes
Rawshani, A., Rawshani, A., Franzén, S., Eliasson, B., Svensson, A.-M., Miftaraj, M., McGuire, D. K., Sattar, N., Rosengren, A., & Gudbjörnsdottir, S. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1608664 · Cited by 1,389
Self-citationAuthors/Task Force Members, Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., et al. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316653709 · Cited by 1,334
Self-citationAn asymptotic equivalence of choice of model by cross validation and Akaike's criterion
Stone, M. (1977) · Journal of the Royal Statistical Society Series B (Statistical Methodology) · doi:10.1111/j.2517-6161.1977.tb01603.x · Cited by 1,286
Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010
Livingstone, S. J., Levin, D., Looker, H. C., Lindsay, R. S., Wild, S. H., Joss, N., Leese, G., Leslie, P., McCrimmon, R. J., Metcalfe, W., et al. (2015) · JAMA · doi:10.1001/jama.2014.16425 · Cited by 621
Self-citation
Cited by
2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes.
Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R. A., Antunes, M. J., Christodorescu, R. M., Crawford, C., Di Angelantonio, E., Eliasson, B., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad192 · Cited by 1,642
Self-citation2024 ESC Guidelines for the management of peripheral arterial and aortic diseases
Mazzolai, L., Teixido-Tura, G., Lanzi, S., Boc, V., Bossone, E., Brodmann, M., Bura-Rivière, A., De Backer, J., Deglise, S., Della Corte, A., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae179 · Cited by 993
Precision prognostics for the development of complications in diabetes
Schiborn, C., & Schulze, M. B. (2022) · Diabetologia · doi:10.1007/s00125-022-05731-4 · Cited by 108
“Fewer models have been developed for the prediction of macrovascular complications in type 1 diabetes; such models include the externally validated Steno T1D Risk Engine [42], the Swedish NDR [43] and the Scottish NDR risk score for type 1 diabetes [44].”
MethodDiabetes risk prediction model based on community follow-up data using machine learning
Jiang, L., Xia, Z., Zhu, R., Gong, H., Wang, J., Li, J., & Wang, L. (2023) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2023.102358 · Cited by 66
Serés‐Noriega, T., Giménez, M., Perea, V., Boswell, L., Viñals, C., Blanco, J., Vinagre, I., Pané, A., Esmatjes, E., Conget, I., et al. (2022) · Diabetes Care · doi:10.2337/dc22-0118 · Cited by 38
Metadata
- Authors
- McGurnaghan, S. J., McKeigue, P. M., Read, S. H., Franzen, S., Svensson, A.-M., Colombo, M., Livingstone, S., Farran, B., Caparrotta, T. M., Blackbourn, L. A. K., Mellor, J., Thoma, I., Sattar, N., Wild, S. H., Gudbjörnsdottir, S., Colhoun, H. M., & on behalf of the Swedish National Diabetes Register and the Scottish Diabetes Research Network Epidemiology Group
- Affiliations
- Institute of Genetics and Cancer (GB)
- University of Edinburgh (GB)
- Women's College Hospital (CA)
- Sahlgrenska University Hospital (SE)
- University of Dundee (GB)
- University of Glasgow (GB)
- NHS Fife (GB)
- Corresponding author
- McGurnaghan, Stuart J.
- Colhoun, Helen M.
- ORCID
- Venue
- Diabetologia
- Published
- 2021-06-09
- Volume
- 64
- Issue
- 9
- Pages
- 2001-2011
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- PMC
- PMC8382639
- OpenAlex
- W3172852952
- Cited by
- 53
- References
- 23
- Citations by year
- 2026: 11 · 2025: 10 · 2024: 13 · 2023: 9 · 2022: 8 · 2021: 2
- FWCI
- 6.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Diabetologia (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion, cc-by)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
- Funders
- Chief Scientist Office (ETM/47)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 1 diabetes, cardiovascular disease, cardiovascular risk prediction models, statin eligibility, statin prescribing, diabetes duration, sex differences, Scotland, Sweden, model validation, calibration, hypercholesterolemia, dyslipidemia, smoking
- MeSH terms
- Heart Disease Risk Factors, Adult, Aged, Cardiovascular Diseases, Diabetes Mellitus, Type 1, Female, Humans, Male, Middle Aged, Quality of Life, Risk Factors, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Development and validation of a cardiovascular risk prediction model in type 1 diabetes. https://app.cochat.ai/papers/10.1007/s00125-021-05478-4
- The paper
- McGurnaghan, S. J., McKeigue, P. M., Read, S. H., Franzen, S., Svensson, A.-M., Colombo, M., Livingstone, S., Farran, B., Caparrotta, T. M., Blackbourn, L. A. K., Mellor, J., Thoma, I., Sattar, N., Wild, S. H., Gudbjörnsdottir, S., Colhoun, H. M., & on behalf of the Swedish National Diabetes Register and the Scottish Diabetes Research Network Epidemiology Group. (2021). Development and validation of a cardiovascular risk prediction model in type 1 diabetes. Diabetologia. https://doi.org/10.1007/s00125-021-05478-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.